(b) Patients with fixed perfusion defects | ||||||||
Univariate analysis | 1.49 | 0.31 | 1.68 | 0.18 | 1.24 | 0.72 | 1.29 | 0.66 |
Adjusted for clinical variables | ||||||||
Age | 1.50 | 0.30 | 1.75 | 0.16 | 1.26 | 0.70 | 1.28 | 0.67 |
Gender | 1.41 | 0.39 | 1.60 | 0.22 | 1.22 | 0.74 | 1.30 | 0.66 |
Age, gender | 1.44 | 0.36 | 1.69 | 0.19 | 1.26 | 0.71 | 1.30 | 0.66 |
DM | 1.42 | 0.39 | 1.63 | 0.23 | 1.19 | 0.78 | 1.26 | 0.40 |
Known CAD | 1.49 | 0.31 | 1.68 | 0.17 | 1.20 | 0.76 | 1.28 | 0.67 |
Previous MI | 1.50 | 0.31 | 1.69 | 0.17 | 1.24 | 0.72 | 1.29 | 0.66 |
Previous PCI | 1.52 | 0.29 | 1.70 | 0.16 | 1.26 | 0.70 | 1.29 | 0.65 |
CAD category* | 1.55 | 0.27 | 1.76 | 0.15 | 1.28 | 0.68 | 1.31 | 0.64 |
CAD category*, previous MI | 1.56 | 0.26 | 1.77 | 0.14 | 1.29 | 0.67 | 1.32 | 0.64 |
CAD category*, previous MI, aspirin, beta blocker, lipid lowering | 1.39 | 0.41 | 1.58 | 0.25 | 1.28 | 0.69 | 1.31 | 0.66 |
Gender, CAD category*, previous MI, aspirin, beta blocker, lipid lowering | 1.34 | 0.47 | 1.51 | 0.30 | 1.27 | 0.69 | 1.32 | 0.65 |
Adjusted for angiographic variables | ||||||||
CCS score (n=223/115) | 1.61 | 0.27 | 1.93 | 0.09 | 0.82 | 0.75 | 0.87 | 0.80 |
Number of stenotic vessels (n=210/108) | 2.35 | 0.09 | 2.67 | 0.06 | 0.74 | 0.65 | 0.77 | 0.69 |
CCS score, number of stenotic vessels (n=210/108) | 1.76 | 0.28 | 2.27 | 0.07 | 0.64 | 0.51 | 0.73 | 0.58 |
Adjusted for scintigraphic variables | ||||||||
At-rest LVEF (n=648/147) | 0.85 | 0.87 | 1.00 | 1.00 | –† | –† | –† | –† |
Post-stress LVEF (n=687/123) | 0.59 | 0.61 | 0.72 | 0.73 | –† | –† | –† | –† |
Size of defects | 1.23 | 0.61 | 1.38 | 0.43 | 1.00 | 1.00 | 1.08 | 0.90 |
Adjusted for selected variables of all types | ||||||||
Gender, CAD category*, previous MI, aspirin, beta blocker, lipid lowering, CCS score (n=223/115) | 1.54 | 0.38 | 1.99 | 0.13 | 0.89 | 0.86 | 0.94 | 0.93 |
Gender, CAD category*, previous MI, aspirin, beta blocker, lipid lowering, number of stenotic vessels (n=210/108) | 3.68 | 0.06 | 4.31 | 0.10 | 0.90 | 0.90 | 0.85 | 0.89 |
Gender, CAD category*, previous MI, aspirin, beta blocker, lipid lowering, CCS score, number of stenotic vessels (n=210/108) | 3.05 | 0.11 | 4.37 | 0.07 | 0.84 | 0.83 | 0.92 | 0.94 |
↵*In order to reduce the number of covariates, and because of correlation between CAD and previous revascularisation, a CAD category variable was generated, taking into account the history of both CAD and previous revascularisation: 1 = suspected CAD; 2 = known CAD with no previous revascularisation; 3 = known CAD with previous revascularisation.
↵†Fitting of Cox model indicated complete separation; hence, no results could be presented.
ACD, all-cause death; CAD, coronary artery disease; CCS, Canadian Cardiovascular Society; CD, cardiac death; CSHR, cause-specific HR; DM, diabetes mellitus; LVEF, left ventricular ejection fraction; MI, myocardial infarction; MPS, myocardial perfusion scintigraphy; PCI, percutaneous coronary intervention; SDHR, subdistribution HR.